PRAME family member 4 (PRAMEF4)

PRAME family member 4 (PRAMEF4) is a protein-coding gene and a member of the PRAME (Preferentially Expressed Antigen of Melanoma) family, also known as cancer-testis antigens[7][9]. While PRAME family proteins are expressed in the testis and are upregulated in various cancers, specific biological roles for PRAMEF4 itself are not well defined. Bioinformatic and functional annotations predict that PRAMEF4 may act as a ubiquitin ligase substrate adaptor, may be involved in proteasome-mediated, ubiquitin-dependent protein catabolic processes, and could bind nuclear retinoic acid receptors, but there is no direct evidence for PRAMEF4 acting as a therapeutic target[7]. Most of the described molecular and disease associations for PRAME family members are based on family-wide studies or are specific to canonical PRAME, not PRAMEF4. PRAMEF4 appears to be primarily cytoplasmic and may participate in protein degradation via the Cullin2-RING E3 ubiquitin ligase complex[7]. There are no known drugs or therapeutics that selectively interact with PRAMEF4, and it is not yet established as a biomarker or therapeutic target in clinical practice. Notes: - The information for PRAMEF4 is limited and largely based on predicted or family-wide functions—individual characterization is lacking in the literature. - Most functional and disease information refers to the PRAME family or canonical PRAME, with potential yet unconfirmed extension to PRAMEF4 itself. - Current evidence does not indicate PRAMEF4 is an established therapeutic target or the focus of drug development.

Other names

PRAMEF4RP5-845O24.6PRAME family member 4